multiple sclerosis

Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

One win was based on the finding that the therapy was non-inferior to Ocrevus, despite the company originally designing the study to show superiority.

Nick Paul Taylor Nov 10, 2025 6:26am

target reach ladder climb meet win beat competition

Zenas autoimmune drug prompts 95% drop in lesions in MS study

Oct 27, 2025 9:25am

Outline of human head with female symbol inside

Diabetes drug soothes brain inflammation in female mice with MS

Oct 15, 2025 6:16pm

Sanofi's troubled MS hopeful tolebrutinib hit by FDA delay

Sep 22, 2025 8:00am

Thermo Fisher debuts protein panel for neurodegeneration R&D

Sep 16, 2025 12:00pm

Contineum shifts cash from MS to lung disease showdown with BMS

Aug 6, 2025 9:51am